Orbital subperiosteal hematoma is a known complication of trauma (1). We are reporting for the first time its occurrence after the combination of thrombolysis and anticoagulation. A 44-year-old man presented with a head injury and brow laceration caused by syncope due to a myocardial infarction. No other ocular problems were noted. He underwent thrombolysis with 40 mg intravenous tenecteplase and was also treated with an infusion of intravenous heparin at a rate of 18 units/kg/h, 300 mg aspirin, 300 mg clopidogrel, and intravenous glyceryl trinitrate at an initial rate of 2.4 mL/h and titrated according to the patient's pain. Seven hours later he complained of headache and double vision. Visual acuity at the bedside was 20/25 in the right eye and 20/20 in the left eye. Ishihara plate color vision was normal. The pupils were of normal size and reactivity. The right eye appeared displaced inward and downward (Fig. 1). He had reduced supraduction and abduction of the right eye and normal ductions in the left eye. There was mild resistance to retropulsion, although no difference in globe displacement was found on Hertel exophthalmometry. He had some bruising and discoloration of his right upper lid. Intraocular pressure using a handheld applanation tonometer was 16 mm Hg in the right eye and 12 mm Hg in the left eye. Results of ophthalmoscopy were normal.FIG. 1: Seven hours after thrombolysis and anticoagulation, the patient complained of diplopia. In primary gaze position, the right eye is displaced downward and inward. The right upper lid is mildly ecchymotic.Brain and orbit CT revealed a frontal extradural hematoma, a temporal subdural hematoma, and a right orbital roof subperiosteal hematoma, with no evidence of an orbital roof fracture (Fig. 2). He was treated with 1 g tranexamic acid daily to inhibit fibrinolysis. All other medications were continued after a long discussion about the risks and benefits of withdrawing medical therapy.FIG. 2: Precontrast sagittal CT shows a superior orbital subperiosteal hematoma (arrow).Two days later visual acuity was 20/20 in both eyes and pupil reactions remained normal. Ophthalmoscopy revealed superotemporal choroidal folds of the right eye. A follow-up brain and orbit CT showed no change in the size of the hematomas. All ocular motility examinations were comparable to his examination on presentation. The diplopia was alleviated with a 30Δ base up Fresnel prism in the right spectacle. Four weeks after the onset of his symptoms, the ocular alignment (Fig. 3) and movements had returned to normal, the diplopia had resolved, and the subperiosteal hematoma had decreased in size.FIG. 3: Four weeks after thrombolysis and anticoagulation, the eyes are in normal position and aligned.The fact that our patient had no visual symptoms on presentation but developed them 7 hours after thrombolysis leads us to believe that the combination treatment consisting of a fibrinolytic, an anticoagulant, and a high-dose antiplatelet agent was responsible for the development of a subperiosteal hematoma. The orbital hematoma was unlikely to have been an extension of the frontal hematoma, as there was no evidence of an orbital roof fracture or communication between the intracranial and orbital compartments. Although early surgical management of subperiosteal hematomas by needle aspiration or surgical evacuation of the hematoma (2-4) may be important for the prevention of significant ocular morbidity, in this case there was no optic nerve compromise and no progression of the ductional deficits, so intervention was not necessary. Kwesi N. Amissah-Arthur, MBChb Victoria Eye Unit Hereford County Hospital Hereford, UK Birmingham and Midland Eye Centre City Hospital Birmingham, UK Markus Groppe, MBBS, MRCOphth Victoria Eye Unit Hereford County Hospital Hereford, UK Prince Charles Eye Unit King Edward VII Hospital Windsor, UK Stephen Scotcher, MBChb, MRCP, FRCOphth Victoria Eye Unit Hereford County Hospital Hereford, UK [email protected]
Read full abstract